Table 1. Characteristics of individuals sampled in cross-sectional surveys.
BASELINE | CS1 | CS2 | CS3 | |||||
Age at vaccination | N | % | N | % | N | % | N | % |
30 months–4 yrs | 44 | 24 | 34 | 25 | 19 | 19 | 8 | 12 |
5 yrs–9 yrs | 22 | 12 | 17 | 13 | 16 | 16 | 13 | 20 |
10–19 yrs | 35 | 19 | 21 | 16 | 24 | 24 | 12 | 18 |
20–39 yrs | 32 | 17 | 22 | 16 | 19 | 19 | 22 | 34 |
40 yrs+ | 38 | 20 | 40 | 30 | 21 | 21 | 10 | 15 |
Unknown | 16 | 9 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 187 | 100 | 134 | 100 | 99 | 100 | 65 | 100 |
Sex | ||||||||
Female | 89 | 48 | 65 | 49 | 59 | 60 | 23 | 35 |
Male | 98 | 52 | 69 | 51 | 40 | 40 | 42 | 65 |
Total | 187 | 100 | 134 | 100 | 99 | 100 | 65 | 100 |
Group | ||||||||
Vaccinated | 89 | 48 | 60 | 45 | 43 | 43 | 31 | 48 |
Not Vaccinated | 98 | 52 | 74 | 55 | 56 | 57 | 34 | 52 |
Total | 187 | 100 | 134 | 100 | 99 | 100 | 65 | 100 |
Days post vaccination | ||||||||
Median (IQR) | 0 | (−77,0) | 116 | (99,127) | 364 | (281,365) | 663 | (626,713) |
A summary of the number of subjects, age category, gender and groups evaluated at baseline and at each cross-sectional samplings (CSS1 to CSS3) are shown.